Ipsen SA

Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital

06 نوفمبر 2023 12:00:00 بحسب Nasdaq GlobeNewswire

IPSEN - Buy-back programme - Art 5 of MAR - Week 43 - 2023

31 أكتوبر 2023 13:00:00 بحسب Nasdaq GlobeNewswire

Ipsen delivers solid sales growth in the first nine months of 2023 and confirms its full-year guidance

26 أكتوبر 2023 01:00:00 بحسب Nasdaq GlobeNewswire

IPSEN - Buy-back program - Art 5 of MAR - Week 42 - 2023

24 أكتوبر 2023 12:00:00 بحسب Nasdaq GlobeNewswire

Ipsen updates on E.U. Marketing Authorisation Application for odevixibat in Alagille syndrome

23 أكتوبر 2023 01:00:00 بحسب Nasdaq GlobeNewswire

IPSEN - Buy-back programme - Art 5 of MAR - Week 41 - 2023

17 أكتوبر 2023 12:00:00 بحسب Nasdaq GlobeNewswire

IPSEN - Buy-back programme - Art 5 of MAR - Week 40 - 2023

10 أكتوبر 2023 12:00:00 بحسب Nasdaq GlobeNewswire

Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital

06 أكتوبر 2023 12:00:00 بحسب Nasdaq GlobeNewswire

Ipsen updates on QM-1114 regulatory process

03 أكتوبر 2023 12:00:00 بحسب Nasdaq GlobeNewswire

IPSEN - Buy-back programme - Art 5 of MAR - Week 39 - 2023

03 أكتوبر 2023 12:00:00 بحسب Nasdaq GlobeNewswire

IPSEN - Buy-back programme - Art 5 of MAR - Week 38 - 2023

26 سبتمبر 2023 12:00:00 بحسب Nasdaq GlobeNewswire

IPSEN - Buy-back programme - Art 5 of MAR - Week 37 - 2023

19 سبتمبر 2023 12:00:00 بحسب Nasdaq GlobeNewswire

IPSEN - Buy-back programme - Art 5 of MAR - Week 36 - 2023

12 سبتمبر 2023 12:00:00 بحسب Nasdaq GlobeNewswire

Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital

08 سبتمبر 2023 12:00:00 بحسب Nasdaq GlobeNewswire

IPSEN - Buy-back programme - Art 5 of MAR - Week 35 - 2023

05 سبتمبر 2023 12:00:00 بحسب Nasdaq GlobeNewswire

Ipsen nominates Pascal Touchon to its Board of Directors as new independent director

04 سبتمبر 2023 01:00:00 بحسب Nasdaq GlobeNewswire

Ipsen announces change in R&D leadership: Howard Mayer to retire, succeeded by Christelle Huguet

01 سبتمبر 2023 01:00:00 بحسب Nasdaq GlobeNewswire

IPSEN - Buy-back programme - Art 5 of MAR - Week 34 - 2023

29 أغسطس 2023 12:00:00 بحسب Nasdaq GlobeNewswire

IPSEN - Buy-back programme - Art 5 of MAR - Week 33 - 2023

22 أغسطس 2023 12:00:00 بحسب Nasdaq GlobeNewswire

Exelixis and Ipsen Announce Positive Results from Phase 3 CONTACT-02 Pivotal Trial Evaluating Cabozantinib in Combination with Atezolizumab in Metastatic Castration-Resistant Prostate Cancer

21 أغسطس 2023 01:00:00 بحسب Nasdaq GlobeNewswire